Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | The future is bright for hematological oncology: promising areas for 2018 and beyond

Kenneth Anderson • 9 Dec 2017
ASH 2017
General

The scientific advances reported at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, were extraordinary. This year’s meeting saw first-time attempts at integrating multiple levels of biological data analysis, including genomics, epigenetics and immunological profiling, which were exciting from both a biological and clinical standpoint. Speaking from the meeting, Kenneth Anderson, MD, of the Dana-Farber Cancer Institute, Boston, MA, and 2017 ASH President, gives his top picks of the most exciting areas of hemonc to look out for over the coming year.

More from Kenneth Anderson

1:27
Collaboration in the myeloma community
Kenneth Anderson • 14 May 2022
4:04
The future of myeloma treatment and the possibility of cure
Kenneth Anderson • 14 May 2022
3:41
Can novel immunotherapies cure multiple myeloma?
Kenneth Anderson • 15 Dec 2020
4:00
Bortezomib-induced immunogenic cell death in myeloma
Kenneth Anderson • 15 Dec 2020

Related Videos

5:23
Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD
Mohamad Mohty • 17 Apr 2024
1:41
The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon • 16 Apr 2024
4:07
Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD
Florent Malard • 11 Apr 2024
2:00
HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors
Rémy Duléry • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals